TUC-S.R.L.
24.4.2024 09:36:30 CEST | Business Wire | Press release
TUC S.r.l., the Deep Tech Company known for TUC.technology, launches a fundamental evolution of its offer, TUC.tiny™. This mobility revolution comes with all the features at the base of the TUC.technology patent, issued in over 140 countries worldwide. A small jewel based on TUC's three technological pillars, mechanical structuring, electronic management and data exchange, designed to also interface with consumer electronics thanks to the integration of USB Type-C technology. TUC.tiny™ becomes the USB of Mobility, a solution that aims to reinvent the interaction between users and vehicles bringing together mobility and everyday life.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424672317/en/
TUC dashboard (Photo: Business Wire)
A real blank canvas, which can be transformed and customized countless times thanks to TUC.tiny™ and TUC.technology™, flexibly adapting to every need and preference. With TUC's innovative patented technology, personal devices such as smartphones, tablets, speakers and voice automation systems can be securely integrated. At the same time, automotive-specific elements such as dashboards, switches for driving mode selection and climate control, navigation systems with integrated cameras, harmonize with accessories that can be used both in the car and at home, such as fragrance diffusers and ambient lights.
TUC S.r.l. is at the forefront of mobility innovation, specialized in the development of modular vehicle solutions that aims to simplify and revolutionize the concept of vehicles, from a defined product to a definable experience. Distinguishing itself for technological excellence at international level, TUC has achieved significant recognition. With the launch of TUC 3.0 in 2023, the company is setting new standards in the industry by partnering with leading global OEMs.
With TUC.tiny™ and its advanced interface – which includes physical fixing, electrical and data transfer connectivity – any device can be integrated into the modular design of the dashboard, making it immediately operational. This allows users to customize their mobile space with extreme ease and freedom. TUC.tiny™ is designed to support all everyday devices that have a USB Type-C connection. These can be integrated into TUC.tiny™ through a state-of-the-art module. The proposed solution stands out for its ability to blend harmoniously into any part of the vehicle, both inside and outside, ensuring direct and simple installation, both in the production phase and after-sales, eliminating the need to adopt inefficient and unsafe solutions such as suction cups or other impractical and unreliable systems. In addition, the robustness of TUC.tiny™ is ensured by a mechanical or electro-actuated locking system, which introduces the novelty of security offered by NFC technology for reliable control of locking and unlocking functions.
"We are proud of the results achieved thanks to our constant commitment over the last few years," comments Ludovico Campana, Inventor and CEO of TUC. “TUC.tiny™ represents our promise for the future; A vision of a world where technology and mobility come together in personalized experiences, designed around the needs of everyone. With TUC.technology®, we enable a paradigm shift, giving vehicle manufacturers tools to simplify development, engineering, and manufacturing, while enabling new business models that enhance continuous post-production customization. Our goal is that it is not the user who adapts to the life cycle of the vehicle, but that the vehicle can evolve to meet the changing needs of its user. We are thrilled with the results obtained by customers who are experimenting and adopting our technology, testifying to the validity and effectiveness of our work – continues Campana – This is the future that TUC S.r.l. is building: a mobility ecosystem where every innovation is guided by the values of democratization of technology, customization and sustainability, with the ambition to overcome current boundaries and explore new possibilities for a more connected and sustainable society. responsible."
The introduction of TUC.tiny™ is the completion of TUC.technology's offering. It marks a step towards the "democratization" of technology. The gateway to an advanced mobility experience becomes wider, easily accommodating the smart objects that animate our daily lives. This isn't just a technological advance; is TUC's invitation to imagine and build together the future of mobility, a world where technology unites us, improving every aspect of our daily journey.
ABOUT TUC.technology
TUC S.r.l. is a Deep-Tech company at the forefront of mobility innovation, specialized in the development of modular vehicle solutions that aim to simplify and revolutionize the concept of the vehicle, from a defined product to a definable experience. Distinguishing itself for technological excellence at an international level, TUC has achieved significant recognition, including exhibitions at CES in Las Vegas at the National Automobile Museum and recognition from major newspapers.
With the launch of TUC 3.0, the company is setting new standards in the industry by partnering with leading global OEMs. Learn more at www.tuc.technology.
Facebook @TUCtechnology
Instagram @tuc.technology
Twitter @TUCtechnology
Linkedin @TUC.technology
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240424672317/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
